On May 16, 2022, MiMedx Group Inc sent a letter to shareholders highlighting the Company strategies and plans in connection with the shareholders value creation. In addition, the Company urged the shareholders to vote for its board nominees at the annual meeting of shareholders scheduled to be held on June 7, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | -1.23% | +1.58% | -26.68% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.68% | 949M | |
-18.52% | 131M | |
+7.32% | 60.9M | |
-15.34% | 61.96M | |
+0.60% | 52.2M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MiMedx Group Inc Mails Letter to Shareholders